Progesterone Receptor-negative Breast Cancer Terminated Phase 2 Trials for RG-4733 (DB11870)

IndicationStatusPhase
DBCOND0028547 (Progesterone Receptor-negative Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01151449Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast CancerTreatment